Seeking Alpha

Microcap biopharmaceutical company Spherix (SPEX +105%) soars after saying that its drug...

Microcap biopharmaceutical company Spherix (SPEX +105%) soars after saying that its drug candidate, SPX-106, achieved statistically significant reductions in VLDL and LDL cholesterol when administered to genetically engineered mice prone to dyslipidemia.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|